Ryvu Therapeutics S.A.
WSE:RVU
48.60
zł0.00 (0.00%)
48.60
zł0.00 (0.00%)
End-of-day quote: 05/04/2024

RVU - Ryvu Therapeutics Stock Prediction 2025 - 2030

13 years of reliable Ryvu Therapeutics stock forecast. The Wall Street analysts predict Outperform for RVU. See at a glance whether WSE:RVU will rise in the future.

zł0.00
Forecast 2023
zł56.42
Forecast 2025
zł88.24
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
zł0.00
Forecast 2025
zł56.42
Forecast 2030
zł88.24
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.6
Price-to-book Ratio
4.33
Market Cap
1.14B
TEV
0.51 B
Dividend
zł0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
zł71.43
Country

Ryvu Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Ryvu Therapeutics Stock Forecast 2023

zł74.25

In the last five quarters, Ryvu Therapeutics’s Price Target has risen from zł54.41 to zł71.43 - a 31.28% increase. Two analysts predict that Ryvu Therapeutics’s share price will increase in the coming year, reaching zł74.25. This would represent an increase of 3.95%.

52.78%
52.78
Last update: 05/05/2024

Highest Price Target zł80.00

Average Price Target zł74.25

Lowest Price Target zł64.00

Ryvu Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Ryvu Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of zł51.99. An increase of 6.97% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of zł52.39. An increase of 7.8% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of zł52.79. An increase of 8.63% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of zł53.20. An increase of 9.46% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of zł53.60. An increase of 10.29% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of zł54.00. An increase of 11.11% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of zł54.40. An increase of 11.94% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of zł54.81. An increase of 12.77% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of zł55.21. An increase of 13.6% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of zł55.61. An increase of 14.43% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of zł56.01. An increase of 15.25% compared to today's share price.

Stock Prediction for the Price of One Ryvu Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of zł56.42. An increase of 16.08% compared to today's share price.

Ryvu Therapeutics Stock Predictions 2030

Ryvu Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of zł81.32. An increase of 67.33% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of zł81.95. An increase of 68.62% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of zł82.58. An increase of 69.92% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of zł83.21. An increase of 71.21% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of zł83.84. An increase of 72.51% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of zł84.47. An increase of 73.8% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of zł85.10. An increase of 75.1% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of zł85.73. An increase of 76.39% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of zł86.36. An increase of 77.69% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of zł86.99. An increase of 78.98% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of zł87.62. An increase of 80.28% compared to the previous month's estimate.

Ryvu Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of zł88.24. An increase of 81.57% compared to the previous month's estimate.

P/E
0.00
Beta
0.6
Price-to-book Ratio
4.33
Market Cap
1.14B
TEV
0.51 B
Dividend
zł0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
zł71.43
Country

Ryvu Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Ryvu Therapeutics S.A.?

The following analysts have recently covered Ryvu Therapeutics:

Biuro maklerskie mBanku
Erste Group Bank AG
Millennium Dom Maklerski Spolka Akcyjna
PKO BP Securities
Santander Brokerage Poland
BNP Paribas Bank Polska Spolka Akcyjna
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Ryvu Therapeutics S.A.?

The following sell-side analysts have recently covered Ryvu Therapeutics:

Szparaga-Wasniewska, Beata
Urbankova, Vladimira
Bugaj, Lukasz
Górzynski, Dawid
Aniol, Adam
Puchalski, Pawel
(This information refers to the last 90 days.)